KeraVision

KeraVision is dedicated to developing a new type of non-laser vision correction product for treating common vision disorders, including myopia, hyperopia, and astigmatism, to provide an alternative to glasses, contact lenses, and other vision correction surgeries. Its first product, the complete corneal ring segment, has been FDA-approved for correcting mild myopia in patients aged 21 or older, with a diopter range of -1.0 to -3.0, stable refraction, and astigmatism not exceeding +1.0.